McDavid Stilwell | VP, Corporate Communications & IR |
Alexander Macrae | CEO, President & Director |
Stéphane Boissel | EVP, Corporate Strategy |
Edward Conner | SVP & Chief Medical Officer |
Kathy Yi | SVP & CFO |
Edward Rebar | SVP & CTO |
Qian Wang | Bank of America Merrill Lynch |
Gena Wang | Barclays Bank |
James Birchenough | Wells Fargo Securities |
Ritu Baral | Cowen and Company |
Whitney Ijem | Guggenheim Securities |
Eric Joseph | JPMorgan Chase & Co. |
Maurice Raycroft | Jefferies |
Good afternoon, and welcome to the Sangamo Therapeutics Teleconference to discuss Third Quarter 2018 Financial Results. This call is being recorded. I will now pass over to the coordinator of the event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.
Hello, and thank you for joining us.
As we begin, I'd like to point out that we will be referring to a slide presentation today.